Evidence map›Paper›PMID 9862577›Full record

Trial reportBritish journal of cancer1998

Expression of a truncated form of hHb1 hair keratin in human breast carcinomas.

C H Régnier, A Boulay, P H Asch, C Wendling, M P Chenard, C Tomasetto, M C Rio

Open access · greenAbstract readClinical TrialControlled Clinical Trial
In one paragraph

Trial report in British journal of cancer, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Keratin 1 as a cell-surface receptor in cancer.Biochimica et biophysica acta. Reviews on cancer · 2022
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

C H RégnierInstitut de Génétique et de Biologie Moléculaire et Cellulaire, Centre National de la Recherche Scientifique/Institut National de la Santé et de la Recherche Médicale U184/Université Louis Pasteur, Illkirch, France.
A Boulay
P H Asch
C Wendling
M P Chenard
C Tomasetto
M C Rio
Hôpitaux Universitaires de Strasbourg · FRInstitut de génétique et de biologie moléculaire et cellulaire · FRHôpital d'Hautepierre · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human hHb1 belongs to the type II hard keratin family and is physiologically expressed in hair shafts. In the present study, using specific 3' and 5' probes for hHb1, we established that breast carcinomas ectopically express a hHb1 5'-truncated mRNA, and that this transcript is restricted to malignant epithelial cells. Furthermore, an in vitro study indicated that it could be translated. We concluded that, in breast carcinomas, expression of truncated hHb1 is related to epithelial cell transformation. Because the hHb1 gene maps to 12q11-q13, a chromosome region known to present several breakpoints in solid tumours, we propose that the hHb1 gene might represent a target for such alterations.

Indexed as

AdultAgedAmino Acid SequenceBase SequenceBlotting, NorthernBreast NeoplasmsCloning, MolecularDNA, ComplementaryFemaleGene Expression Regulation, NeoplasticHairHumansKeratinsMiddle AgedMolecular Sequence DataProtein BiosynthesisDNA, ComplementaryKeratins

Identifiers

PMID9862577
PMCPMC2063233
OpenAlexW2058194607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.